Advanced search
Publication Cover
Neuro-Ophthalmology Volume 42, 2018 - Issue 1
Submit an article Journal homepage
107
Views
5
CrossRef citations to date
0
Altmetric
Case Reports

Sibling Ethambutol Optic Chiasmopathy

Viran JayanettiConcord Repatriation General Hospital, Concord, New South Wales, AustraliaCorrespondence[email protected]
,
Michael Rossiter-ThorntonConcord Repatriation General Hospital, Concord, New South Wales, Australia
,
Domit AzarConcord Repatriation General Hospital, Concord, New South Wales, Australia
&
Clare L. FraserMacquarie University Clinic, Macquarie University, Sydney, New South Wales, Australia
Pages 40-43 | Received 31 Jan 2017, Accepted 20 Apr 2017, Published online: 30 May 2017

References

  • Lim S. Ethambutol-associated optic neuropathy. Ann Acad Med Singapore 2006;35:274.
  • Kho RC, Al-Obailan M, Arnold AC. Bitemporal visual field defects in ethambutol-induced optic neuropathy. J Neuro-ophthalmol 2011;2:121–126.
  • Pott JWR, Wong KH. Leber’s hereditary optic neuropathy and vitamin B12 deficiency. Graefes Arch Clin Exp Ophthalmol 2006;244:1357–1359.
  • Seo JH, Hwang JM, Park SS. Antituberculosis medication as a possible epigenetic factor of Leber’s hereditary optic neuropathy. Clin Exp Ophthalmol 2010;38:363–366.
  • Hwang J-M, Kim J, Park SS. Leber’s hereditary optic neuropathy mutations in ethambutol-induced optic neuropathy. J Neurol 2003;250:87–89.
  • Pommer R, Schoeler S, Mawrin C, Szibor R, Kirches E. The G11778A LHON mutation does not enhance ethambutol cytotoxicity in a cybrid model. Clin Neuropathol 2008;27:414–423.
  • Fonkem E, Skordilis MA, Binkley EM, Raymer DS, Epstein A, Arnold WD, Kissel JT, Lawson VH. Ethambutol toxicity exacerbating the phenotype of CMT2A2. Muscle Nerve 2013;48:140–144. doi: 10.1002/mus.23766.
  • Guillet V, Chevrollier A, Cassereau J, Letournel F, Gueguen N, Richard L, Desquiret V, Verny C, Procaccio V, Amati-Bonneau P, Reynier P, Bonneau D. Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity. Mitochondrion 2010;10:115–124. doi: 10.1016/j.mito.2009.11.004.
  • Pradhan M, Sharp D, Best S, Vincent A, Vaphiades M. Drug-induced optic neuropathy—TB or not TB. Surv Ophthalmol 2010;55:378–385. doi: 10.1016/j.survophthal.2009.10.005.
  • Acaroglu G, Kansu T, Dogulu CF. Visual recovery patterns in children with Leber’s hereditary optic neuropathy. Int Ophthalmol 2001;24:349–355.
  • Tsai R-K, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther 1997;13:473–477.
  • Kesler A, Pianka P. Toxic optic neuropathy. Curr Neurol Neurosci Rep 2003;3:410–414.
  • Carelli V, on behalf of the Consensus Study Group. Consensus on guidelines for idebenone administration in Leber’s hereditary optic neuropathy (LHON). Acta Ophthalmol 2016. doi: 10.1111/j.1755-3768.2016.0502.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.